Create a narrative

BioStem Technologies Community

OTCPK:BSEM Community

1 Narratives written by author
1 Comments on narratives written by author
37 Fair Values set on narratives written by author

BioStem Technologies

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

VENDAJE AC National Launch And BioRetain Data To Drive Future Market Expansion

Key Takeaways Strategic collaborations and successful CMS partnerships can enhance market adoption and pricing stability, boosting net margins and profitability. Expanding clinical trials and NASDAQ uplisting may increase revenue, earnings, and shareholder value through broader market access and investor reach.

US$49.56

FV

85.3% undervalued

27.09%

Revenue growth p.a.

0

1

16

5 months ago